Washington Company Secures $40 Million In Funding
Written on Mar 31, 2009
Pathway Medical Technologies, Inc. recently announced that it has secured a $40 million Series D round of financing, reports DeviceSpace. Raising such a large amount of capital is a rare achievement for a medical device venture, particularly in today’s tough economic climate. Pathway President and CEO Paul...
Good News for Market-Leading Stent
Written on Mar 31, 2009
A new study by Abbott Laboratories found that their drug-coated stent, Xience V, is more effective in the long term than a competitor’s. According to the Wall Street Journal, the data showed that rates of major cardiovascular events (such as heart attacks) plateaued at 6.4% in the second and third years...
Written on Mar 31, 2009
The Medical Device Manufacturers Association (MDMA) 2009 Annual Meeting will bring together executives from innovative medical technology companies and healthcare’s most influential and respected decision makers. Please plan to join the MDMA in our Nation’s Capital for a meeting that stimulates new...
Spider Technology Helps Repair Damaged Tissue
Written on Mar 30, 2009
Look out, Spider-Man. A British company has reproduced the silk that spider webs are made out of, for use in repairing bone and joint injuries. Spidrex tissue scaffolds, developed by Oxford Biomaterials, work in tandem with the body’s ability to heal itself. The protein-based product initially supports...
Fantastic Voyage: Researchers Develop Miniature Surgical Robots
Written on Mar 30, 2009
It sounds like something out of a sci-fi film: microscopic robots that can be injected into the bloodstream to perform surgical procedures. This futuristic concept is closer to reality than one might think. Researchers at Australia’s Monash University have created tiny surgical microbots to treat...
[Video Profile] TearLab Corporation
Written on Mar 29, 2009
Patients who dread traditional blood tests (and the accompanying needles) may one day have reason to rejoice. San Diego device company TearLab is developing a point-of-care diagnostic test that uses tears to identify disease-indicating protein biomarkers. Tears contain many of the same proteins as blood, but...
[Video Profile] Inovio Biomedical Corporation
Written on Mar 26, 2009
Solid tumors represent 85 percent of all cancers, creating a huge clinical need for localized, site-specific cancer treatment. Inovio Medical Corporation of San Diego is developing DNA-based vaccines that harness the body’s immune system to prevent and treat chronic diseases such as cancer and HIV. Their...
